Brief: India's Morepen Laboratories Gets U.S. FDA Nod For Bulk Drug Montelukast Sodium
20/12/2017 04:31
Dec 20 (Reuters) - Morepen Laboratories Ltd MORL.NS :
* GETS U.S. FDA CLEARANCE FOR ITS BULK DRUG MONTELUKAST
SODIUM
Source text - http://bit.ly/2B2xrcK
Further company coverage: MORL.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Morepen Laboratories
See all newsBrief: Morepen Laboratories Says High Court Quashes Notice Seeking Recovery Of 1.18 Billion Rupees
India's Morepen Laboratories gains on U.S. FDA submission for Sitagliptin tablets
Brief: Morepen Laboratories Submits First U.S. ANDA For Sitagliptin Tablets USP In Three Strengths
Brief: Morepen Laboratories Ltd June-Quarter Consol Net Profit 563.5 Million Rupees
India's Morepen Laboratories slips after quarterly profit fall